Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥843.5B | ¥832.5B | +1.3% |
| Operating Income | ¥99.5B | ¥82.2B | +21.1% |
| Ordinary Income | ¥121.3B | ¥62.8B | +93.2% |
| Net Income | ¥65.4B | ¥46.4B | +40.8% |
| ROE | 4.0% | 2.8% | - |
Executive Summary
The first half of FY2026 saw increases in both revenue and profit; however, it should be noted that the main driver of profit growth was improvement in the core business, while foreign exchange gains contributed to the sharp increase in ordinary income. Revenue was ¥843.5B (+1.3% YoY), operating income was ¥99.5B (+21.1%), ordinary income was ¥121.3B (+93.2%), and net income was ¥65.4B (+40.8%). Although revenue growth was modest, the operating margin improved by approximately 1.9pt YoY to 11.8%, driven by improved profitability in the core Beauty Care Business. The substantial increase in ordinary income was primarily attributable to ¥19.6B in foreign exchange gains recorded as non-operating income; excluding this factor, the improvement on a core operating basis was more moderate.
Factors Affecting Performance
【Revenue】Revenue was ¥843.5B, representing modest growth of +1.3% YoY. The core Beauty Care Business accounted for the majority at ¥812.7B (composition ratio: 96.4%, +1.4% YoY), while the Real Estate Business at ¥18.0B (+4.1%) and Other Businesses at ¥26.2B (+5.6%) also achieved revenue growth, although both remained small in scale. Overall growth was limited, and the primary focus for the current period has been improving profitability rather than expanding volume.
【Profit and Loss】Operating income was ¥99.5B (+21.1% YoY), with the decline in SG&A expenses YoY contributing to profit growth while the gross margin was maintained at 81.2%. Segment profit in the Beauty Care Business was ¥99.5B (+23.4%, margin: 12.2%), making it the central driver of the improvement in consolidated earnings. Ordinary income surged to ¥121.3B (+93.2% YoY), largely due to ¥19.6B in foreign exchange gains included in non-operating income, which have a temporary nature. Following extraordinary losses of ¥22.4B, including ¥20.8B in business restructuring expenses, net income was ¥65.4B (+40.8% YoY). In conclusion, the Company achieved increases in both revenue and profit. At the operating income level, this represents high-quality profit growth driven by core business improvement, while at the ordinary income and net income levels, the growth includes the volatile factor of foreign exchange gains.
Segment Analysis
The Beauty Care Business recorded revenue of ¥812.7B (+1.4% YoY) and segment profit of ¥99.5B (+23.4% YoY), accounting for the majority of consolidated profit, while its profit margin improved from the previous year to 12.2%. The Real Estate Business achieved revenue growth to ¥18.0B (+4.1%), but segment profit declined to ¥4.2B (-1.4% YoY), reducing its profit margin to 23.6%. Other Businesses (building maintenance) recorded revenue of ¥26.2B (+5.6%) and profit of ¥1.0B (+47.1%), reflecting improved profitability. Adjustments for corporate expenses and other items increased in negative magnitude, offsetting part of the improvement in segment profits.
Key Financial Indicators
【Profitability】The operating margin of 11.8% and net profit margin of 7.8% both improved from the same period of the previous year. The Company maintained its high-value-added structure, with a gross margin of 81.2%, while improving SG&A efficiency. 【Cash Flow Quality】The difference between ordinary income and net income was primarily attributable to extraordinary losses of ¥22.4B, including ¥20.8B in restructuring expenses, and income taxes and other taxes of ¥33.5B. The 93.2% increase in ordinary income includes the non-recurring factor of ¥19.6B in foreign exchange gains. 【Investment Efficiency】ROE for the cumulative first-half period was 4.0%, or approximately 8% on an annualized basis. The asset structure, in which cash and deposits of ¥498.9B and investment securities of ¥209.4B account for significant proportions of total assets of ¥1971.7B, is restraining capital efficiency. 【Financial Soundness】The equity ratio was 82.1%, and interest-bearing debt was negligible. The Company continues to maintain a conservative financial position, with current assets substantially exceeding current liabilities.
Cash Flow Analysis
Although there is no separate disclosure of the cash flow statement, an analysis of fund movements based on changes in the balance sheet indicates that cash and deposits declined to ¥498.9B from ¥597.1B at the end of the previous fiscal year, while current securities increased from ¥109.6B, suggesting that a portion of funds was allocated to short-term investments. Inventories remained broadly flat at ¥126.8B. With virtually no interest-bearing debt, funds generated from business activities may have been primarily allocated to on-hand liquidity and additional investment securities. Total assets and net assets both decreased slightly from the end of the previous fiscal year, and capital allocation remained at a conservative level.
Earnings Quality
Operating income of ¥99.5B accounted for 11.8% of revenue, reflecting improved profitability in the core business. Meanwhile, foreign exchange gains of ¥19.6B accounted for the majority of non-operating income of ¥23.4B and served as a factor pushing ordinary income up to ¥121.3B. Foreign exchange gains were equivalent to approximately 19.7% of operating income, indicating a structure in which ordinary income and net income are susceptible to fluctuations if foreign exchange rates reverse. Of extraordinary losses of ¥22.4B, business restructuring expenses accounted for ¥20.8B, compressing profit before tax to ¥98.9B. Comprehensive income was ¥55.6B, below net income of ¥65.4B; the difference was attributable to a negative ¥13.1B in foreign currency translation adjustments, with the yen translation impact on overseas assets and foreign subsidiaries creating the divergence from net income. Overall, improvement at the operating income level was of high quality, while the rates of increase in ordinary income and net income included mixed non-recurring factors.
Earnings Forecast and Guidance
The first-half progress rates against the full-year forecasts (revenue of ¥1730.0B, operating income of ¥173.0B, ordinary income of ¥173.0B, and EPS of ¥40.67) were 48.8% for revenue, 57.5% for operating income, and 70.1% for ordinary income. While revenue progress was broadly in line with the standard 50% level, operating income progress exceeded the standard level, reflecting the improvement in profitability during the first half. The particularly high progress rate for ordinary income was attributable to the contribution from foreign exchange gains, and it cannot be assumed that non-operating income will continue at the same level in the second half. The full-year forecast calls for operating income growth of only +10.2% YoY, incorporating a slowdown in the pace of profit growth from +21.1% in the first half toward the second half. No revision has been made to the earnings forecast.
Shareholder Returns
The Q2 dividend was ¥21.00 per share, and the full-year dividend forecast is ¥52.00 (assuming a year-end dividend of ¥31.00). The payout ratio based on actual first-half net income is approximately above 70%, while the forecast payout ratio based on the full-year net income forecast of ¥90.0B is approximately 127.9%. Although the dividend plan exceeds the level of earnings, the strong financial foundation—an equity ratio of 82.1%, cash and deposits of ¥498.9B, and virtually no interest-bearing debt—supports the current shareholder return policy. There has been no disclosure regarding share repurchases; accordingly, the payout ratio here is based solely on dividends.
Risk Factors
-
Concentration of profit in the core business: Segment profit in the Beauty Care Business of ¥99.5B accounts for nearly all consolidated operating income, creating a structure in which changes in demand trends and brand competitiveness in this business directly affect consolidated performance.
-
Foreign exchange sensitivity: Foreign exchange gains of ¥19.6B included in non-operating income are equivalent to 19.7% of operating income, and ordinary income and net income are susceptible to fluctuations in foreign exchange rates. If foreign exchange rates reverse, the growth rate at the ordinary income level could contract significantly.
-
Temporary nature of restructuring expenses: Business restructuring expenses accounted for ¥20.8B of extraordinary losses of ¥22.4B, compressing profit before tax. Whether these expenses lead to improved fixed-cost efficiency will influence the medium-term trend in profit margins.
Industry Benchmark (For Reference; Compiled by the Company)
Profitability and Return
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 11.8% | 9.7% (5.4%–23.7%) | +2.1pt |
| Net Profit Margin | 7.8% | 5.4% (1.3%–20.1%) | +2.3pt |
Both the operating margin and net profit margin exceed the industry median, indicating that profitability is relatively high within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 1.3% | 10.6% (-3.4%–25.4%) | −9.3pt |
The revenue growth rate is substantially below the industry median, indicating that top-line expansion is relatively modest within the industry.
※Source: Compiled by the Company
Key Points from the Earnings Results
-
While revenue growth was limited to +1.3% YoY, operating income increased by +21.1%, and the operating margin improved from the same period of the previous year. The defining feature of the current period is improved profitability without reliance on top-line expansion.
-
The +93.2% increase in ordinary income was supported by ¥19.6B in foreign exchange gains. It should therefore be noted that the nature of improvement at the operating income level differs from the growth rates at the ordinary income and net income levels.
-
The forecast payout ratio is approximately 127.9% of the full-year net income forecast, exceeding the level of earnings; however, the financial foundation, including an equity ratio of 82.1% and negligible interest-bearing debt, supports the current shareholder return policy.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥657 |
| base | ¥670 |
| bull | ¥675 |
| Calculation Assumption | Value |
|---|---|
| Book Value Per Share (BPS) | ¥730 |
| Adjusted Forecast EPS | ¥44.7 |
| Cost of Equity r | 9.27% (10-year government bond 2.77% + equity risk premium 6.00% + size premium 0.50%) |
| Persistence Factor of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 100.0% |
| Forecast EPS Confidence Adjustment | ×1.100 (based on leading progress against the full-year forecast) |
| Implied PBR / PER | 0.92x / 15.0x |
Sensitivity: ¥652–¥688 for a ±1% change in the cost of equity, and ¥668–¥671 for a ±0.1 change in ω.
Notes:
- Since net income progress against the full-year forecast (73%) exceeds the standard level (50%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies with leading progress tend to exceed forecasts; the adjustment may be excessive for businesses with strong seasonality).
- Net income is substantially compressed relative to operating income due to the tax burden, acquisition-related expenses, and non-controlling interests, among other factors (net income ÷ operating income: 52%). This figure reflects that compression at face value; if the factors are temporary, the underlying earnings power may be higher.
- Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
- Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
(Calculation model: Residual Income Model (Ohlson type; explicit five-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q2 results were operationally stronger, with modest sales growth translating into material operating-profit expansion, although below-the-line restructuring charges and elevated inventory intensity temper the quality of the headline recovery. Revenue rose 1.3% YoY to ¥84.35bn. Operating income increased 21.1% to ¥9.95bn, substantially outperforming the top line. The operating margin improved by 190bp to 11.8% from 9.9% in the prior-year period. Gross profit increased 0.7% to ¥68.52bn, but the gross margin eased by approximately 50bp to 81.2%, indicating that the earnings improvement was not driven by gross-margin expansion. SG&A expense declined 2.1% YoY to ¥58.56bn despite revenue growth, creating favorable operating leverage. Ordinary income surged 93.2% to ¥12.14bn, aided by a ¥4.02bn YoY swing from a foreign-exchange loss in the prior period to a ¥1.96bn foreign-exchange gain in the current period. Net income rose 40.8% to ¥6.54bn, less than ordinary-income growth because extraordinary losses increased to ¥2.24bn from ¥0.52bn. Restructuring costs of ¥2.08bn were the principal extraordinary item and equaled 31.8% of interim net income. The Beauty Care business remained the core earnings engine, contributing ¥9.95bn of segment profit before corporate adjustments. Beauty Care segment profit expanded 23.4% YoY despite only 1.3% sales growth, evidencing improved cost discipline. The balance sheet remains exceptionally liquid, with a 370.4% current ratio, ¥49.89bn of cash and deposits, and only ¥0.26bn of interest-bearing debt. However, inventory days are elevated under both reported quality-alert measures, and the reported cash conversion cycle is extended, requiring close attention to sell-through and markdown risk. The interim dividend is ¥21 per share, while the unchanged full-year DPS forecast of ¥52 implies a high payout relative to forecast EPS. Management maintained full-year guidance, but Q2 progress is already above the standard 50% pace for operating income, ordinary income, and net income. The second-half outlook therefore depends on whether the Beauty Care margin recovery can continue without further restructuring charges, inventory pressure, or adverse foreign-exchange movements.
Profitability Analysis
Reported annualized ROE is 8.1%, composed of a 7.8% net profit margin, 0.856x asset turnover, and 1.22x financial leverage. The largest earnings-driver change was margin improvement rather than leverage, as financial leverage remains low and the company is overwhelmingly equity financed. The operating margin expanded to 11.8% from 9.9%, while the gross margin slipped modestly to 81.2% from approximately 81.7%. This indicates that SG&A discipline, rather than pricing or product-mix-led gross-margin gains, was the main source of operating leverage. SG&A fell to ¥58.56bn from ¥59.83bn, a 2.1% YoY reduction against 1.3% revenue growth. The 11.8% operating margin is within the good 8-15% benchmark range, while the 7.8% net margin is also within the good 5-10% range. The five-factor DuPont tax burden was 0.661, reflecting an effective tax rate of 33.9%, while the 0.994 interest burden confirms that interest costs are immaterial. The gap between operating income and ordinary income was unusually large: ordinary income exceeded operating income by ¥2.18bn, primarily due to ¥1.96bn of FX gains. Non-operating income was 2.8% of revenue, below the 5% threshold for an unusually large non-operating contribution, but FX accounted for 19.7% of operating income and remains material to interim earnings. The gap between ordinary income and net income was 46.1%, driven chiefly by ¥2.24bn of extraordinary losses, including ¥2.08bn of restructuring costs. Accordingly, the operating-margin improvement appears more recurring than the ordinary-income increase, whereas the latter was amplified by FX gains. The annualized ROE of 8.1% is near but only modestly above the 8% concern threshold, constrained by low leverage and relatively modest asset turnover rather than weak liquidity or debt capacity.
Growth Assessment
Sales growth was modest at 1.3% YoY, so the Q2 recovery was primarily profit-led rather than volume-led. Beauty Care revenue increased 1.3% to ¥81.27bn and represented 96.3% of consolidated external revenue. Its segment profit rose 23.4% to ¥9.95bn, and the segment margin improved to 12.2% from 10.0% a year earlier. This demonstrates meaningful operating leverage in the core franchise. Real Estate revenue increased 4.7% to ¥1.56bn, but segment profit declined 1.4% to ¥0.43bn and its margin fell to 27.3% from 29.0%. The Other business, comprising building maintenance, recorded a 2.8% revenue decline to ¥1.52bn but a 47.1% increase in segment profit to ¥0.10bn. Consolidated corporate and elimination costs increased to ¥0.52bn from ¥0.35bn, partly offsetting segment-level gains. Full-year sales guidance is ¥173.00bn, and Q2 sales progress is 48.8%, broadly in line with the standard 50% first-half pace. Operating-income progress is 57.5% against full-year guidance of ¥17.30bn, 7.5 percentage points ahead of the standard pace. Ordinary-income progress is 70.1%, 20.1 percentage points above the standard pace, principally reflecting favorable interim FX gains. Net-income progress is 72.7% against the ¥9.00bn forecast, also well above the standard pace but affected by the timing of extraordinary charges and non-operating gains. Since full-year guidance was not revised, the implied second-half operating income is ¥7.35bn, below the first-half result, and the implied second-half net income is ¥2.46bn. This embedded second-half moderation suggests that management does not assume the first-half pace of margin gains and FX benefits will fully persist.
Financial Health
Financial health is strong. Current assets of ¥98.76bn exceed current liabilities of ¥26.66bn by ¥72.10bn, producing a 370.4% current ratio and ¥72.10bn of working capital. The 322.9% quick ratio confirms that liquidity is not dependent on inventory monetization. Cash and deposits totaled ¥49.89bn, equal to 1.87x current liabilities. Interest-bearing debt was only ¥0.26bn, including ¥0.07bn of current maturities, compared with total equity of ¥161.79bn. The reported debt-to-equity ratio of 0.22x is conservative and is far below the 2.0x warning threshold; debt/capital is reported at 0.0%. Interest coverage of 174.63x demonstrates negligible financing-cost pressure. There is no material maturity mismatch, as current assets vastly exceed short-term obligations and current debt maturities are immaterial. Total liabilities were only 17.9% of total assets, while the equity ratio was 81.9%. Investment securities increased by ¥6.30bn YoY to ¥20.94bn, a 43.0% increase that raises exposure to market-value movements, although it is supported by a very strong capital base. Trade payables rose 36.1% YoY to ¥3.00bn, but remain modest relative to cost of sales and do not alter the liquidity assessment. Asset retirement obligations totaled ¥3.79bn, equal to 10.7% of total liabilities, representing a material long-dated obligation that should be monitored in relation to facility-use and remediation assumptions. Intangible assets were ¥10.92bn, or 5.5% of total assets, well below the 20% concentration benchmark; software accounted for ¥10.82bn, indicating that nearly all recognized intangibles are software-related rather than acquisition goodwill.
Notable B/S Changes
Cash and deposits: -¥9.83bn YoY to ¥49.89bn - lower cash was broadly offset by increased holdings of short-term and longer-term investment securities, indicating asset reallocation rather than a liquidity shortfall. Short-term investment securities: +¥6.01bn YoY to ¥10.96bn - increased deployment of liquid funds into securities should be monitored for market-value and liquidity effects. Investment securities: +¥6.30bn (+43.0%) YoY to ¥20.94bn - materially higher financial-asset exposure increases sensitivity to valuation movements, although it remains well supported by equity. Accounts receivable: -¥1.05bn YoY to ¥16.59bn - lower receivables support collection efficiency and contrast favorably with the inventory-related working-capital concern. Accounts payable: +¥0.80bn (+36.1%) YoY to ¥3.00bn - supplier credit increased, but the absolute balance remains modest and estimated annualized payable days remain around 35 days. Current assets: -¥6.39bn YoY to ¥98.76bn, while noncurrent assets increased ¥5.66bn to ¥98.41bn - the asset mix shifted away from cash and toward investments, with total assets broadly stable. Total equity: -¥1.30bn YoY to ¥161.79bn - the decline despite interim profitability reflects distributions and negative comprehensive-income components, including foreign-currency translation effects.
Cash Flow Quality
The strong operating result cannot be directly validated through operating cash flow or free cash flow in the provided figures, so cash conversion should be assessed primarily through working-capital indicators. Inventory totaled ¥12.68bn, with finished goods also reported at ¥12.68bn, making finished-goods exposure central to the working-capital profile. Using interim cost of sales annualized for the six-month period, inventory days are approximately 146 days, above the 90-day warning level. A separate quality alert reports inventory days of 205 days; both reported measures indicate slow inventory conversion and require attention. The reported quality alert also identifies a 207-day cash conversion cycle, well above the 120-day warning threshold. On an annualized balance-sheet calculation using trade receivables, inventories and trade payables, receivable days are approximately 36 days, payable days approximately 35 days, and the cash conversion cycle approximately 147 days; this remains elevated even under the shorter measure. The root cause is high inventory relative to cost of sales rather than slow customer collections, as estimated receivable days are within the sub-45-day efficiency benchmark. The extended inventory cycle is particularly relevant for a beauty-products business because it can increase the risk of aging stock, promotional spending, and inventory write-downs if demand or product renewal is weaker than anticipated. Raw materials were ¥4.29bn and work in process was ¥0.84bn, suggesting that the alert is concentrated in finished goods rather than production bottlenecks. The ¥9.83bn YoY decline in cash and deposits was partly accompanied by a ¥6.01bn increase in short-term investment securities and a ¥6.30bn increase in investment securities, consistent with a reallocation of liquid funds toward financial investments rather than evidence of balance-sheet stress. The working-capital profile is therefore the principal cash-quality issue, notwithstanding very strong absolute liquidity.
Dividend Sustainability
The interim dividend is ¥21.00 per share. The calculated interim payout ratio is 73.6% based on the disclosed methodology, which is above the conventional sub-60% sustainability benchmark but below a 100% warning level. Full-year DPS guidance is unchanged at ¥52.00 per share. Against forecast EPS of ¥40.67, the implied full-year dividend payout ratio is approximately 127.9%, above 100%. This means the full-year dividend policy is not expected to be fully covered by forecast accounting earnings. The company has substantial balance-sheet capacity, including ¥49.89bn of cash and deposits, a 370.4% current ratio, and negligible interest-bearing debt, which supports its ability to maintain shareholder distributions in the near term. However, the high expected payout increases the importance of continued operating-profit recovery and disciplined investment requirements. No share buyback data is provided, so the analysis is limited to the dividend payout ratio rather than a total return ratio. The implied ¥31.00 per-share year-end dividend exceeds the ¥21.00 interim dividend and concentrates a significant portion of annual distributions in the second half. Dividend sustainability is therefore supported by financial strength but is less well covered by forecast earnings, making the normalization of operating cash conversion and inventory levels important.
Risk Assessment
Business risks include Beauty Care concentration: the core Beauty Care segment accounts for 96.3% of external revenue, so demand, competitive positioning, product-cycle execution, and channel performance in this business disproportionately determine group earnings., Inventory and product-obsolescence risk: quality alerts show inventory days of 205 days and an annualized balance-based measure of approximately 146 days, both above warning thresholds. High finished-goods exposure can lead to markdowns, promotional intensity, or write-down risk if sell-through slows., Foreign-exchange volatility: the ¥1.96bn FX gain represented 19.7% of operating income and was the principal reason ordinary-income growth exceeded operating-income growth. A reversal would reduce below-the-line earnings momentum., Margin sustainability: operating-margin expansion was driven by SG&A reduction while gross margin declined modestly. Sustained profit growth will require continued expense discipline without undermining brand investment, advertising effectiveness, or product innovation., Real Estate profitability: Real Estate segment sales rose 4.7%, but segment profit declined 1.4%, indicating some margin pressure in a smaller diversification business..
Financial risks include Asset retirement obligations of ¥3.79bn equal 10.7% of liabilities, above the 5% quality-alert threshold. The root cause is a sizable long-dated restoration obligation associated with property and facilities. This is material relative to liabilities, though it is readily manageable relative to the ¥161.79bn equity base and strong liquidity., Securities exposure increased: investment securities rose ¥6.30bn YoY to ¥20.94bn, and valuation changes can affect OCI and, depending on classification, earnings., The forecast full-year dividend payout ratio is approximately 127.9%, implying that distributions are expected to exceed forecast EPS. While solvency is robust, this reduces retained-earnings coverage if earnings weaken..
Key concerns include Highest priority: convert elevated inventories into sales without margin-eroding promotions or impairment/write-downs; the reported 207-day cash conversion cycle suggests capital remains tied up for an extended period., High priority: distinguish recurring operating improvement from the non-recurring or market-sensitive components of earnings. Restructuring costs were ¥2.08bn, while FX gains were ¥1.96bn., Medium priority: assess whether SG&A reductions can be sustained while preserving Beauty Care growth, brand equity, and customer acquisition., Medium priority: monitor the rise in investment securities and the negative ¥0.98bn other comprehensive income, which reduced comprehensive income below net income..
Investment Implications
Key takeaways include Operating performance improved materially: operating income rose 21.1% YoY and the operating margin expanded 190bp to 11.8%., The Beauty Care business is the core business and delivered a 23.4% rise in segment profit on 1.3% sales growth., Ordinary-income growth of 93.2% overstates recurring operating momentum because it includes a substantial favorable FX swing., Interim net income includes ¥2.24bn of extraordinary losses, primarily ¥2.08bn of restructuring costs, which suppresses comparability with operating earnings., The balance sheet is exceptionally strong, with 81.9% equity capitalization, ¥49.89bn cash and deposits, and immaterial interest-bearing debt., Inventory efficiency and the associated extended cash conversion cycle are the most important operational risk indicators., Full-year operating-income progress is ahead of the normal first-half pace, but unchanged guidance implies a slower second half., The forecast full-year dividend payout ratio exceeds 100%, making earnings durability and cash conversion important for distribution coverage..
Metrics to watch include Beauty Care sales growth, segment margin, and promotional/advertising spending, Gross margin versus SG&A ratio, to determine whether operating-margin gains remain sustainable, Finished-goods inventory, inventory days, and the cash conversion cycle, FX gains or losses relative to operating income, Restructuring-cost recurrence and subsequent savings realization, Full-year operating-income progress against the ¥17.30bn forecast, Investment-securities valuation movements and OCI, Dividend coverage relative to forecast EPS and operating cash generation.
Regarding relative positioning, The company is positioned as a financially conservative, high-gross-margin consumer beauty group with a strong capital base and negligible debt. Its 11.8% operating margin is solid, but annualized ROE of 8.1% is only moderate because the business employs low financial leverage and modest asset turnover. Relative operating quality is strengthened by expense-led margin expansion, while relative risk is concentrated in inventory conversion, FX-sensitive non-operating earnings, and a dividend level that exceeds forecast EPS.